News

Former FDA commissioner petitions to restrict ultra-processed foods

Dr. David Kessler, former FDA commissioner, has formally petitioned RFK Jr. to remove key ingredients in ultra-processed ...

FDA's New Expert Panels Are Rife With Financial Conflicts and Fringe Views

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

FDA approves ketamine product for surgical pain management

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

FDA Approves Novo Nordisk’s Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...
MedPage Today on MSN13h

Semaglutide Gets FDA Greenlight for MASH

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease

CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...

The FDA Let Substandard Factories Ship These Medications to the U.S.

ProPublica identified more than 150 products that were exempted from import bans since 2013. Our list provides the names of ...

Drug Approvals Hit an FDA Wall

Therapies for rare and deadly disease are dying in Marty Makary’s shop.

Time is running out for kids with a rare disease, parents say, unless the FDA acts

After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...

Stealth resubmits rare disease drug to FDA

The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...
STAT15h

Conflicts among CDC and FDA vaccine panel members are not as numerous as you think, study finds

Robert F. Kennedy Jr. has said the CDC's vaccine advisory board was rife with conflicts of interest. A new analysis shows ...